Log In
Print
BCIQ
Print
Print this Print this
 

intetumumab (BGB-101, CNTO-95)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionHuman mAb against integrin alpha(V) that targets integrin alpha (V)beta(3) (CD51/CD61); integrin alpha(V)beta(5); integrin alpha (V)beta(6); and Integrin alpha(V)beta(1) (CD51/CD29)
Molecular Target Integrin alpha(V)beta(3) (CD51/CD61) ; Integrin alpha(V)beta(5)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today